Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2482-2488, October 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, T.
Right arrow Articles by Momparler, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, T.
Right arrow Articles by Momparler, R. L.

Kinetic Studies on Phosphorylation of 5-Azacytidine with the Purified Uridine-Cytidine Kinase from Calf Thymus1

Thomas Lee, Myron Karon2 and Richard L. Momparler

Division of Hematology-Oncology, University of Southern California School of Medicine and Childrens Hospital of Los Angeles, Los Angeles, California 90027

Uridine-cytidine kinase was purified 330-fold from calf thymus. This enzyme catalyzes the phosphorylation of uridine, cytidine (CR), and the nucleoside analog, 5-azacytidine (5-aza-C) to their respective nucleoside 5'-monophosphates in the presence of Mg++ and adenosine 5'-triphosphate. The Km values for CR uridine, and 5-aza-C were 40, 50, and 200 µM respectively. Uridine 5'-triphosphate or cytidine 5'-triphosphate inhibited the phosphorylation of these nucleosides; the inhibition was noncompetitive with respect to the nucleoside substrates and competitive with respect to adenosine 5'-triphosphate. CR and uridine were potent competitive inhibitors of 5-aza-C (Ki values of 40 and 50 µM, respectively), whereas 5-aza-C was a weak competitive inhibitor of CR (Ki value of 200 µM).

1 This publication was supported in part by Grant CI-85-D from the American Cancer Society and NIH Grants CA 11050 and CA 14089.

2 Scholar of Leukemia Society of America.

Received 3/19/74. Accepted 6/ 7/74.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J. C. Cheng, C. B. Matsen, F. A. Gonzales, W. Ye, S. Greer, V. E. Marquez, P. A. Jones, and E. U. Selker
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
J Natl Cancer Inst, March 5, 2003; 95(5): 399 - 409.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. R. Van Rompay, A. Norda, K. Lindén, M. Johansson, and A. Karlsson
Phosphorylation of Uridine and Cytidine Nucleoside Analogs by Two Human Uridine-Cytidine Kinases
Mol. Pharmacol., April 16, 2001; 59(5): 1181 - 1186.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.